NCT02364336View on ClinicalTrials.gov

Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 14, 2015

Primary Completion Date

May 21, 2018

Study Completion Date

May 21, 2018

Conditions
Chronic Hepatitis B
Interventions
DRUG

Peginterferon alfa-2a

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT02364336 - Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment | Biotech Hunter | Biotech Hunter